Why Addiction and Anxiety/Depression So Often Happen Together

If you have an addiction and also struggle with anxiety or depression, you are not unusual. You are actually in the majority. Co-occurring substance use disorders and mental health conditions, called dual diagnosis, are more the rule than the exception in people seeking addiction treatment. Roughly 50 percent of people with a substance use disorder also have at least one co-occurring mental health condition, according to SAMHSA data.

Understanding why addiction and anxiety or depression so often appear together changes how treatment should be approached. It also helps remove the confusion and shame that many people feel about “having so many problems.” These conditions are not separate failures. They share biological roots, reinforce each other, and in many cases are two expressions of the same underlying vulnerability.

How Common Is Dual Diagnosis?

• Approximately 9.5 million adults in the US have co-occurring substance use and mental health disorders
• People with anxiety disorders are 2 to 3 times more likely to have an alcohol use disorder
• Major depression doubles the risk of a substance use disorder
• Only about 9 percent of people with dual diagnosis receive treatment for both conditions
• Treating only one condition without the other significantly reduces the likelihood of sustained recovery

The Three Models of Why They Co-Occur

Researchers have proposed several explanations for why addiction and mental health disorders co-occur so frequently. Each applies in different cases, and often more than one is operating at the same time.

1. Self-Medication

The self-medication hypothesis proposes that people with untreated or under-treated anxiety or depression turn to substances because they provide temporary relief from symptoms. Alcohol reduces anxiety acutely because it enhances GABA (a calming neurotransmitter) and inhibits glutamate (an excitatory one). Cannabis can decrease the subjective experience of anxiety at low doses. Opioids can dull emotional pain as well as physical pain. Stimulants can temporarily relieve the energy deficit and executive dysfunction of depression.

The relief is real, and it works in the short term. The problem is that the brain adapts to the substance over time, requiring more to get the same effect, and the underlying psychiatric condition often worsens with sustained use, as the substance disrupts the very neurochemical systems that regulate mood and anxiety.

Self-medication is not a character flaw. It is a rational response to unmanaged symptoms. But the treatment is more specific and effective when the mental health condition is identified and treated directly, not just masked.

2. Substance-Induced Mental Health Disorders

Chronic heavy use of addictive substances can cause anxiety or depression as a direct physiological consequence. Alcohol-induced depression is a well-documented phenomenon: alcohol suppresses the central nervous system, and with chronic use, the neurochemical imbalances it creates produce depressive symptoms that can be as severe as major depressive disorder.

Stimulants like cocaine and methamphetamine, through their depletion of dopamine and serotonin with chronic use, can produce profound depression during cessation. Cannabis, particularly with heavy high-THC use, is associated with increased anxiety and, in some studies, elevated rates of panic disorder in long-term users.

In these cases, treating the substance use disorder is the primary intervention for the mental health symptoms. But the co-occurring symptoms still need to be monitored and addressed because the person may have a heightened vulnerability that continues after abstinence.

3. Shared Genetic and Neurobiological Vulnerability

The third model, which carries perhaps the strongest scientific support, is that addiction and mental health disorders share underlying genetic and neurobiological risk factors. Twin studies and genome-wide association studies have identified overlapping genetic variants that increase risk for both alcohol use disorder and major depression, and for both anxiety disorders and substance use disorders.

These shared roots operate through overlapping neurobiological systems, particularly the dopamine reward path, the hypothalamic-pituitary-adrenal (HPA) stress axis, and serotonin signaling. When these systems are dysregulated through genetics, trauma, early adversity, or epigenetic factors, they create vulnerability to both conditions.

“The high rate of co-occurrence between substance use disorders and psychiatric disorders is not coincidental. It reflects overlapping neural circuitry, shared genetic architecture, and the direct neurobiological effects of substances on mental health systems.” — NIDA, Comorbidity Report, 2021

Childhood Trauma as a Common Root

Adverse childhood experiences (ACEs) including abuse, neglect, parental substance use, and household instability are strongly associated with both mental health and substance use disorders in adulthood. The ACE study, one of the largest studies of its kind, found that each additional ACE score point dramatically increased the likelihood of both depression and heavy alcohol or drug use in adulthood.

Childhood trauma affects the development of the stress response system, alters hippocampal volume, and increases baseline cortisol levels. These changes increase both the vulnerability to mood and anxiety disorders and the rewarding properties of substances that temporarily reduce the heightened stress response.

Effective dual diagnosis treatment often needs to address the underlying trauma as part of the treatment plan, not just the presenting symptoms of anxiety, depression, and substance use.

Why Treating One Without the Other Does Not Work

Addiction treatment that ignores the co-occurring anxiety or depression sends the person back into the community with the same unmanaged symptoms that drove them to substances in the first place. Without treatment for the mental health condition, the pull toward self-medication remains strong, and relapse is highly probable.

Conversely, mental health treatment that ignores substance use fails for similar reasons. Antidepressants or anti-anxiety medications are significantly less effective when the person continues to use alcohol or other substances, which interfere with medication metabolism and continue to disrupt the neurochemical systems the medications are trying to stabilize.

Integrated treatment, meaning simultaneous treatment of both conditions by a coordinated team, produces better outcomes than sequential or parallel treatment. This is now considered the standard of care for dual diagnosis by SAMHSA, NIDA, and major addiction medicine organizations.

What Effective Dual Diagnosis Treatment Looks Like

Integrated Assessment

Diagnosis of the mental health condition should ideally be made after an adequate period of abstinence, because active substance use distorts all psychiatric symptom presentations. Symptoms assessed during active intoxication or acute withdrawal may not reflect the person’s true baseline. A careful clinical history that distinguishes substance-induced symptoms from pre-existing conditions guides treatment planning.

Evidence-Based Psychiatric Treatment

Depending on the specific mental health condition:

• Major depression: SSRIs, SNRIs, and evidence-based psychotherapy (particularly CBT and behavioral activation)
• Generalized anxiety disorder: SSRIs, SNRIs, buspirone, and CBT
• PTSD: Trauma-focused CBT, EMDR, prolonged exposure, and in some cases prazosin for nightmares
• Bipolar disorder: Mood stabilizers and careful monitoring, as stimulants and alcohol significantly worsen bipolar cycling

Substance Use Disorder Treatment

Integrated programs address both conditions simultaneously. Medication-assisted treatment for opioid or alcohol use disorder proceeds alongside psychiatric medication and therapy for the co-occurring condition. Therapists trained in both areas address the interplay between the conditions in session.

Peer Support and Community

Recovery communities that explicitly welcome and address dual diagnosis, such as Dual Recovery Anonymous and some SMART Recovery meetings, provide peer support from people who understand the complexity of the co-occurring experience.

Getting the Right Diagnosis and Care

If you have struggled with addiction and also experience anxiety or depression, it is worth seeking evaluation from a psychiatrist or addiction medicine physician who has dual diagnosis experience. Many primary care and addiction settings still treat only one condition. Finding a provider or program that addresses both is not always easy, but it significantly improves outcomes.

SAMHSA’s Treatment Locator (findtreatment.gov) allows you to filter for programs that specifically offer dual diagnosis services. The effort to find a program that treats the whole picture is worth it. You are not a difficult case. You are a person with two connected, treatable conditions who deserves treatment that understands both.